Trial Profile
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in U.S. Children.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Meningitis; Pneumococcal infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 24 Nov 2015 New trial record